Edwards Lifesciences Ownership & Insider Activity

Edwards Lifesciences (EW) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.3% of shares outstanding. Institutional investors hold 64.2%. Over the past 90 days, insiders made 6 sales worth $705K.

Shares Outstanding

576.400M

Shares Float

506.486M

Insider Shares Owned

1.986M

Insider % Owned

0.3%

Institutional Shares Held

369.795M

Institutional % Held

64.2%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$705K total

Net Activity

Net Selling

Net Value (90d)

-$705K

Edwards Lifesciences Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 31, 2026	Andrew Dahl	SVP, CORPORATE CONTROLLER	SELL	544.000	$91.06	$50K
Aug 28, 2026	Annette Bruls	CVP, EMEACLA	SELL	2.644K	$89.98	$238K
Aug 26, 2026	Daveen Chopra	CVP, TMTT, SURGICAL & IHFM	SELL-OPTIONS	—	$81.85	$583K
Aug 26, 2026	Wayne Markowitz	CVP, JAPAC	SELL	1.240K	$91.47	$113K
Aug 11, 2026	Daniel Lippis	CVP, TAVR	SELL-OPTIONS	—	$82.36	$12K
Jul 30, 2026	Wayne Markowitz	CVP, JAPAC	SELL	146.313	$86.03	$13K
Jul 28, 2026	Wayne Markowitz	CVP, JAPAC	SELL-OPTIONS	—	$79.54	$106K
Jul 27, 2026	Bernard Zovighian	CEO	SELL	2.921K	$83.93	$245K
Jul 10, 2026	Daniel Lippis	CVP, TAVR	SELL-OPTIONS	—	$82.19	$12K
Jun 30, 2026	Daniel Lippis	CVP, TAVR	SELL-OPTIONS	—	$82.04	$12K
Jun 17, 2026	Bernard Zovighian	CEO	SELL	523.000	$87.92	$46K
May 29, 2026	Andrew Dahl	SVP, CORPORATE CONTROLLER	SELL	567.527	$86.08	$49K
May 27, 2026	DONALD BOBO JR	CVP,STRATEGY/CORP DEVELOPMENT	SELL	23.145K	$86.42	$2.0M
May 22, 2026	Daveen Chopra	CVP, TMTT & SURGICAL	SELL	1.500K	$84.60	$127K
May 18, 2026	Daniel Lippis	CVP, TAVR	SELL-OPTIONS	—	$76.91	$5K
May 15, 2026	DONALD BOBO JR	CVP,STRATEGY/CORP DEVELOPMENT	SELL	17.968K	$81.96	$1.5M
May 11, 2026	Bernard Zovighian	CEO	SELL	15.342K	$78.78	$4.9M
May 7, 2026	Wayne Markowitz	CVP, JAPAC	GRANT	4.117K	$81.21	$88K
May 1, 2026	Daniel Lippis	CVP, TAVR	SELL	252.000	$71.40	$71K
Apr 9, 2026	Scott Ullem	CVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$69.65	$270K
Apr 6, 2026	Daniel Lippis	CVP, TAVR	SELL-OPTIONS	—	$70.12	$22K
Apr 2, 2026	DONALD BOBO JR	CVP,STRATEGY/CORP DEVELOPMENT	SELL-OPTIONS	—	$69.71	$474K
Mar 11, 2026	Scott Ullem	CVP, CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$72.09	$334K
Mar 11, 2026	Daniel Lippis	CVP, TAVR	SELL-OPTIONS	—	$72.32	$27K

More with Benzinga EdgeGet Access

Congressional Trading Activity

Date	Member	Party	Chamber	Action	Amount
Mar 27, 2026	Alan Armstrong	R	Senate	P	$1,001 - $15,000
Nov 19, 2025	Josh Gottheimer	D	House	S	$1,001 - $15,000
May 12, 2025	Jefferson Shreve	R	House	S	$50,001 - $100,000
Apr 21, 2025	Bruce Westerman	R	House	S	$1,001 - $15,000
Apr 8, 2025	Robert Bresnahan	R	House	P	$1,001 - $15,000
Apr 7, 2025	Jefferson Shreve	R	House	P	$15,001 - $50,000
Mar 3, 2025	Bruce Westerman	R	House	P	$1,001 - $15,000
Aug 20, 2024	Markwayne Mullin	R	Senate	S (Partial)	$15,001 - $50,000
Apr 11, 2024	Mike Kelly	R	House	S	$1,001 - $15,000
Dec 11, 2023	Josh Gottheimer	D	House	P	$1,001 - $15,000
Dec 4, 2023	John Curtis	R	House	S	$1,001 - $15,000
Oct 3, 2023	Markwayne Mullin	R	Senate	P	$1,001 - $15,000
Sep 13, 2023	Markwayne Mullin	R	Senate	P	$15,001 - $50,000

More with Benzinga EdgeGet Access

Edwards Lifesciences Corp